What's new? Log in Free sign up

111 (YI)

Company Profile

Company profile

Ticker

YI

Exchange

Website

CEO

Mr. Junling Liu

Incorporated

Location

Fiscal year end

Sector

Health Care and Social Assistance > Pharmaceuticals

Industry (SIC)

Retail - Drug Stores and Proprietary Stores

CVS Health • Walgreens Boots Alliance • New Rite Aid • Covetrus • Guardian Pharmacy Services • China Jo-Jo Drugstores • PetMed Express • Dougherty's Pharmacy • Dragon Jade International • Progressive Care ...

Former names

Kitov Pharma Ltd., Kitov Pharmaceuticals Holdings Ltd.

SEC CIK

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Material Contracts & Credit Agreements

Subsidiaries Lists

YI stock data

1M 3M 6M 1Y

Latest filings (excl ownership)

View all

111, Inc. Announces Third Quarter 2024 Unaudited Financial Results

111, Inc. Announces Change to Board of Directors

111, Inc. Announces Second Quarter 2024 Unaudited Financial Results

Current report (foreign)

111, Inc. Announces First Quarter 2024 Unaudited Financial Results

Annual report (foreign)

14 May 24

Notice of late annual filing (foreign)

111, Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results

111 Announces Receipt of Withdrawal of Going Private Proposal

111, Inc. Announces Third Quarter 2023 Unaudited Financial Results

Transcripts

View all

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Latest ownership filings

ClearVue Partners, L.P.

Verlinvest Asia (HK) Ltd

ClearVue Partners, L.P.

Financial summary

Financial statements Chart YI financial data

Quarter (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from 111 earnings reports.

Institutional ownership, Q2 2023

YI institutional ownership history Ownership history

78.0% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	16	19	-15.8%
Opened positions	1	2	-50.0%
Closed positions	4	2	+100.0%
Increased positions	6	3	+100.0%
Reduced positions	2	6	-66.7%

13F shares	Current	Prev Q	Change
Total value	3.70 bn	4.20 bn	-11.9%
Total shares	63.79 mm	63.85 mm	-0.1%
Total puts	100.00	100.00	–
Total calls	100.00	0.00	NEW
Total put/call ratio	1.0	Infinity	NaN%

Largest owners	Shares	Value	Change
Gang Yu	36.00 mm	$0.00	0.0%
ClearVue Partners	18.35 mm	$64.22 mm	0.0%
Verlinvest Asia	7.62 mm	$136.00 mm	0.0%
JPM JPMorgan Chase & Co.	724.92 k	$1.78 bn	-1.1%
Greenwoods Asset Management Hong Kong	348.86 k	$858.06 mm	0.0%
BCS Barclays	329.80 k	$811.00 k	0.0%
Renaissance Technologies	151.35 k	$372.00 k	+35.9%
STT State Street	93.23 k	$229.35 mm	+6.3%
Prelude Capital Management	48.50 k	$119.29 mm	+3.2%
Geode Capital Management	33.10 k	$81.43 mm	0.0%

Largest transactions	Shares	Bought/sold	Change
IVZ Invesco	0.00	-56.07 k	EXIT
Renaissance Technologies	151.35 k	+40.00 k	+35.9%
Marshall Wace	0.00	-23.54 k	EXIT
Two Sigma Investments	0.00	-17.50 k	EXIT
Citadel Advisors	26.66 k	-15.40 k	-36.6%
JPM JPMorgan Chase & Co.	724.92 k	-8.23 k	-1.1%
STT State Street	93.23 k	+5.56 k	+6.3%
Rhumbline Advisers	5.25 k	+5.25 k	NEW
Tower Research Capital	10.34 k	+4.79 k	+86.3%
Connor, Clark & Lunn Investment Management	30.98 k	+1.87 k	+6.4%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

News

From Benzinga Pro

Earnings Scheduled For November 27, 2024

111 Q3 Adj. EPADS $(0.02) Up From $(0.12) YoY, Sales $513.09M Miss $534.67M Estimate

111 (NASDAQ:YI) reported quarterly losses of $(0.02) per share. This is a 83.33 percent increase over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $513.09 million

Press releases

From Benzinga Pro

111, Inc. Announces Third Quarter 2024 Unaudited Financial Results

Maintained Operational Profitability for the Third Consecutive QuarterOperating Expenses as a Percentage of Revenues Decreased 160 Basis Points YoYHeld Positive Operating Cash Flow for Three Consecutive QuartersSHANGHAI,

111, Inc. to Participate in Fireside Chat with Water Tower Research on December 6, 2024

SHANGHAI, Nov. 21, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by

111 Reschedules Third Quarter 2024 Unaudited Financial Results Announcement to November 27, 2024 - Conference Call to Follow

SHANGHAI, Nov. 4, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by

111, Inc. Announces Change to Board of Directors

111, Inc. to Participate in Fireside Chat with Water Tower Research on October 30, 2024

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.